{
    "2020-04-01": [
        [
            {
                "time": "2020-03-15",
                "original_text": "Pharma Giant Eli Lilly (LLY) Stock is a Buy During the Coronavirus Economy",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "stock",
                        "buy",
                        "coronavirus"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-04-01",
                "original_text": "Merck, Pfizer, Eli Lilly launch worker volunteer programs to aid in coronavirus fight",
                "features": {
                    "keywords": [
                        "Merck",
                        "Pfizer",
                        "Eli Lilly",
                        "volunteer",
                        "coronavirus"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-04-10",
                "original_text": "Medical Professionals Across Merck & Co., Inc., Pfizer Inc., and Eli Lilly and Company Activate to Support Health Systems, First Responders and Patients Amid COVID-19 Pandemic",
                "features": {
                    "keywords": [
                        "medical professionals",
                        "Merck",
                        "Pfizer",
                        "Eli Lilly",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-06-20",
                "original_text": "Is Eli Lilly and (LLY) Outperforming Other Medical Stocks This Year?",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "outperforming",
                        "medical stocks"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-15",
                "original_text": "3 Drugmakers Still Worth Betting on Amid Coronavirus Woes",
                "features": {
                    "keywords": [
                        "drugmakers",
                        "betting",
                        "coronavirus"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08-10",
                "original_text": "Is There An Opportunity With Eli Lilly and Company's (NYSE:LLY) 25% Undervaluation?",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "undervaluation"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}